The Effect of glna Loss on the Physiological and Pathological Phenotype of Parkinson's Disease C. elegans.

Qifei Liang, Guangrong Zhao
Author Information
  1. Qifei Liang: Tongji University School of Medicine, Shanghai, China.
  2. Guangrong Zhao: Tongji University School of Medicine, Shanghai, China. ORCID

Abstract

BACKGROUND: Parkinson's disease (PD) is a common neurodegenerative disease. Glutamate(Glu) excitotoxicity is one of the main pathogenesis of PD. Glutaminase (Gls) is an enzyme primarily responsible for catalyzing the hydrolysis and deamidation of glutamine (Gln) to produce Glu and ammonia. Inhibiting the function of Gls may have a beneficial effect on the treatment of PD by reducing the production of Glu. The homologous gene of Gls in C. elegans is glna.
AIMS: To explore the effects of glna loss on physiological and pathological phenotype of PD C. elegans, and to provide new ideas and references for the research and treatment of PD.
MATERIALS & METHODS: We used PD C. elegans UA44 and QIN27 to detect development and lifespan, behavior, degeneration of dopaminergic neurons, lipid levels, ROS levels, expression levels of common amino acids.
RESULTS: Glna loss had no significant impact on the development and lifespan of PD C. elegans. Glna loss saved part of the decline of motor function, including the head thrash frequency and the body bend frequency, and the difference was significant. There was a trend of improvement in some motor behaviors, such as the ethanol avoidance experiment, while no improvement was observed in other experiments. Glna loss slowed down the degeneration of dopaminergic neurons. Glna loss increased the lipid levels and ROS levels in C. elegans. Glna loss decreased Glu content and increased Gln content in C. elegans.
DISCUSSION: The effect of glna loss on PD C. elegans may be the result of multiple factors, such as the tissue types of ��-syn expression in C. elegans, the PD C. elegans model used, the adverse effects of glna loss on other systems, and the changes in ROS levels in C. elegans. The specific mechanisms causing these phenomena are still unclear and need to be further explored.
CONCLUSION: Glna loss has a certain protective effect on dopaminergic neurons in PD C. elegans, while the improvement effect on movement and behavior is limited.

Keywords

References

  1. Nat Commun. 2015 May 11;6:7107 [PMID: 25960195]
  2. Transl Neurodegener. 2022 Jan 25;11(1):3 [PMID: 35078537]
  3. Science. 2003 Oct 31;302(5646):841 [PMID: 14593171]
  4. WormBook. 2006 Oct 25;:1-29 [PMID: 18050433]
  5. PLoS Genet. 2014 Nov 13;10(11):e1004741 [PMID: 25393002]
  6. Brain. 2022 Oct 21;145(10):3472-3487 [PMID: 35551349]
  7. Lancet. 2015 Aug 29;386(9996):896-912 [PMID: 25904081]
  8. Nature. 2019 Jul;571(7763):63-71 [PMID: 31270481]
  9. J Comp Neurol. 1975 Sep 15;163(2):215-26 [PMID: 240872]
  10. Bio Protoc. 2018 Mar 20;8(6): [PMID: 29744374]
  11. Curr Opin Genet Dev. 2017 Jun;44:102-109 [PMID: 28242493]
  12. PeerJ. 2022 Feb 01;10:e12866 [PMID: 35178301]
  13. Cell Rep. 2023 Jul 25;42(7):112712 [PMID: 37384529]
  14. Int J Mol Sci. 2023 May 22;24(10): [PMID: 37240432]
  15. Front Endocrinol (Lausanne). 2020 Oct 05;11:554994 [PMID: 33123086]
  16. Front Genet. 2017 Jun 13;8:77 [PMID: 28659967]
  17. Environ Pollut. 2019 Jan;244:947-957 [PMID: 30469289]
  18. Int J Mol Sci. 2021 Jul 16;22(14): [PMID: 34299248]
  19. J Neurosci. 2005 Apr 13;25(15):3801-12 [PMID: 15829632]
  20. Sci Rep. 2016 Mar 15;6:22940 [PMID: 26976078]
  21. Dis Model Mech. 2020 Oct 26;13(10): [PMID: 33106318]
  22. J Ethnopharmacol. 2021 Oct 28;279:114347 [PMID: 34147616]
  23. Brain Sci. 2019 Mar 28;9(4): [PMID: 30925741]
  24. Annu Rev Neurosci. 2007;30:259-88 [PMID: 17600522]
  25. Int J Mol Sci. 2013 Nov 21;14(11):23103-28 [PMID: 24284401]
  26. Neuroscience. 2019 Jan 1;396:175-186 [PMID: 30472430]
  27. WormBook. 2006 Feb 11;:1-11 [PMID: 18050451]
  28. J Neurochem. 2003 Jul;86(1):165-72 [PMID: 12807436]
  29. Genetics. 1974 May;77(1):71-94 [PMID: 4366476]
  30. Acta Pharm Sin B. 2022 Feb;12(2):665-677 [PMID: 35256938]
  31. J Pharmacol Exp Ther. 2019 Mar;368(3):382-390 [PMID: 30552293]
  32. Biosci Rep. 2001 Jun;21(3):247-69 [PMID: 11892993]
  33. Genome Res. 2000 May;10(5):703-13 [PMID: 10810093]
  34. Trends Biochem Sci. 2021 Apr;46(4):329-343 [PMID: 33323315]
  35. J Alzheimers Dis. 2020;77(1):437-447 [PMID: 32675407]
  36. BMC Genomics. 2019 Mar 20;20(1):232 [PMID: 30894116]
  37. iScience. 2023 Feb 15;26(3):106206 [PMID: 36876125]
  38. Free Radic Biol Med. 2018 Dec;129:310-322 [PMID: 30266681]
  39. Cold Spring Harb Perspect Med. 2012 Dec 01;2(12):a009621 [PMID: 23071379]
  40. Nat Med. 1998 Nov;4(11):1318-20 [PMID: 9809558]
  41. Biochem Biophys Res Commun. 2011 Oct 7;413(4):605-10 [PMID: 21925152]
  42. Cell Mol Life Sci. 2022 Mar 26;79(4):210 [PMID: 35347432]
  43. J Mol Neurosci. 2018 Mar;64(3):385-396 [PMID: 29441491]
  44. J Neurosci. 2014 Mar 12;34(11):3947-58 [PMID: 24623772]
  45. J Neurochem. 2015 May;133(4):582-9 [PMID: 25580849]
  46. Nat Rev Drug Discov. 2006 May;5(5):387-98 [PMID: 16672925]

MeSH Term

Animals
Caenorhabditis elegans
Parkinson Disease
Caenorhabditis elegans Proteins
Dopaminergic Neurons
Phenotype
Reactive Oxygen Species
Glutaminase
Longevity
Disease Models, Animal

Chemicals

Caenorhabditis elegans Proteins
Reactive Oxygen Species
Glutaminase

Word Cloud

Created with Highcharts 10.0.0CelegansPDlossglnalevelsGlnaGlueffectdopaminergicneuronsGlsROSimprovementParkinson'sdiseasecommonGlnfunctionmaytreatmenteffectsuseddevelopmentlifespanbehaviordegenerationlipidexpressionsignificantmotorfrequencyincreasedcontentBACKGROUND:neurodegenerativeGlutamateexcitotoxicityonemainpathogenesisGlutaminaseenzymeprimarilyresponsiblecatalyzinghydrolysisdeamidationglutamineproduceammoniaInhibitingbeneficialreducingproductionhomologousgeneAIMS:explorephysiologicalpathologicalphenotypeprovidenewideasreferencesresearchMATERIALS&METHODS:UA44QIN27detectaminoacidsRESULTS:impactsavedpartdeclineincludingheadthrashbodybenddifferencetrendbehaviorsethanolavoidanceexperimentobservedexperimentssloweddecreasedDISCUSSION:resultmultiplefactorstissuetypes��-synmodeladversesystemschangesspecificmechanismscausingphenomenastillunclearneedexploredCONCLUSION:certainprotectivemovementlimitedEffectLossPhysiologicalPathologicalPhenotypeDisease

Similar Articles

Cited By

No available data.